Principal Investigator
Nicolas Yannuzzi
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20210558
Clinical Trial Summary
A Phase 2a, Prospective, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Assess the Safety, Tolerability and Evidence of Activity of a Single Intravitreal Injection of UBX1325 in Patients with Diabetic Macular Edema
Phase
Phase II
Funding Agency/Sponsor
Intramural
Disease
Retina
Contact Information
Study Contact
Marlene Perez
Phone Number
+1 (305) 4824309
Email
mcolon@miami.edu